Literature DB >> 22458518

Pancreatic cancer: between bench and bedside.

Davide Melisi, Alfredo Budillon.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22458518     DOI： 10.2174/138945012800564130

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN： 1389-4501            Impact factor:   3.465


× No keyword cloud information.
  9 in total

1.  HMGN5 promotes proliferation and invasion via the activation of Wnt/β-catenin signaling pathway in pancreatic ductal adenocarcinoma.

Authors:  Jianwen Zhao; Yong Wang; Xinglong Wu
Journal:  Oncol Lett       Date:  2018-07-05       Impact factor: 2.967

2.  Current status of biomarker and targeted nanoparticle development: The precision oncology approach for pancreatic cancer therapy.

Authors:  Lei Zhu; Charles Staley; David Kooby; Bassel El-Rays; Hui Mao; Lily Yang
Journal:  Cancer Lett       Date:  2016-12-01       Impact factor: 8.679

3.  An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis.

Authors:  Carmine Carbone; Geny Piro; Matteo Fassan; Anna Tamburrino; Maria Mihaela Mina; Marco Zanotto; Paul J Chiao; Claudio Bassi; Aldo Scarpa; Giampaolo Tortora; Davide Melisi
Journal:  Oncotarget       Date:  2015-05-30

4.  Early detection of pancreatic cancer in mouse models using a novel antibody, TAB004.

Authors:  Shu-Ta Wu; Chandra D Williams; Priyanka A Grover; Laura J Moore; Pinku Mukherjee
Journal:  PLoS One       Date:  2018-02-20       Impact factor: 3.240

5.  Multicenter Retrospective Analysis of Second-Line Therapy after Gemcitabine Plus Nab-Paclitaxel in Advanced Pancreatic Cancer Patients.

Authors:  Valeria Merz; Alessandro Cavaliere; Carlo Messina; Massimiliano Salati; Camilla Zecchetto; Simona Casalino; Michele Milella; Orazio Caffo; Davide Melisi
Journal:  Cancers (Basel)       Date:  2020-04-30       Impact factor: 6.639

6.  Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy.

Authors:  Anna Tamburrino; Geny Piro; Carmine Carbone; Giampaolo Tortora; Davide Melisi
Journal:  Front Pharmacol       Date:  2013-04-30       Impact factor: 5.810

7.  Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling.

Authors:  C Carbone; G Piro; N Gaianigo; F Ligorio; R Santoro; V Merz; F Simionato; C Zecchetto; G Falco; G Conti; P T Kamga; M Krampera; F Di Nicolantonio; L De Franceschi; A Scarpa; G Tortora; D Melisi
Journal:  Int J Obes (Lond)       Date:  2017-11-20       Impact factor: 5.095

Review 8.  EMT and Treatment Resistance in Pancreatic Cancer.

Authors:  Nicola Gaianigo; Davide Melisi; Carmine Carbone
Journal:  Cancers (Basel)       Date:  2017-09-12       Impact factor: 6.639

Review 9.  Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance.

Authors:  Priscilla Cascetta; Alessandro Cavaliere; Geny Piro; Lorena Torroni; Raffaela Santoro; Giampaolo Tortora; Davide Melisi; Carmine Carbone
Journal:  Int J Mol Sci       Date:  2018-10-25       Impact factor: 5.923
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.